Home / Companies / Cancer Research And Development / Trends
Cancer Research And Development H-1B trends
Quarterly LCA aggregate trend points for Cancer Research And Development. Each point carries filing counts, distinct employers, distinct role titles, SOC coverage, wage metrics, certification counts, and source IDs when returned.
Summary
H-1B LCA filings for Cancer Research And Development span 2023 Q2 to 2023 Q3, peaking at 1 filings in 2023 Q2.
The most recent reported period (2023 Q3) shows 1 filings.
LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
| Period | LCA count | Role titles | SOC codes | Avg wage low | Avg prevailing | Certified | Certification rate |
|---|---|---|---|---|---|---|---|
| 2023 Q2 | 1 | 1 | 1 | $111,000 | $110,947 | 0 | 0.0% |
| 2023 Q3 | 1 | 1 | 1 | $110,240 | $110,240 | 1 | 100.0% |
Frequently asked questions
- How have H-1B filings for Cancer Research And Development changed over time?
- H-1B LCA filings for Cancer Research And Development span 2023 Q2 to 2023 Q3, peaking at 1 filings in 2023 Q2. The most recent reported period (2023 Q3) shows 1 filings. LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Get this page with API
Rendered from the bluedoor H-1B Jobs API. Reproduce it:
GET https://api.bluedoor.sh/h1b-jobs/v1/trends?company=cancer+research+and+development&metric=lca_countJSON